AT80312T
Improved penetration enhancers for transdermal drug delivery of systemic agents.
Abstract
This record has no abstract on file.
Term
Term ended
Expired 20 May 2003, 23.3 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
64 members in 12 offices
Priority claims7
| Document | Office | Kind | Date |
|---|---|---|---|
| 38016182 | United States of America | A | |
| 38016182 | United States of America | A | |
| 83105041 | European Patent Office (EPO) | A | |
| 380161 | – | – | – |
| 83105041 | – | – | – |
| EP19830105041 | – | – | – |
| US19820380161 | – | – | – |
Members64
| Document | Office | Kind | |
|---|---|---|---|
| BE843140A | Belgium | A | |
| US3989815A | United States of America | A | |
| US3989816A | United States of America | A | |
| US3991203A | United States of America | A | |
| IE43241L | Ireland | L | |
| DE2627772A1 | Germany | A1 | |
| JPS521035A | Japan | A | |
| FR2314731A1 | France | A1 | |
| AU1506376A | Australia | A | |
| US4122170A | United States of America | A | |
| FR2314731B1 | France | B1 | |
| GB1553309A | United Kingdom | A | |
| GB1553310A | United Kingdom | A | |
| AU504943B2 | Australia | B2 | |
| CA1076028A | Canada | A | |
| IE43241B1 | Ireland | B1 | |
| US4316893A | United States of America | A | |
| EP0077078A1 | European Patent Office (EPO) | A1 | |
| AU8926782A | Australia | A | |
| JPS5874601A | Japan | A | |
| US4405616A | United States of America | A | |
| US4415563A | United States of America | A | |
| AU1439383A | Australia | A | |
| EP0095169A2 | European Patent Office (EPO) | A2 | |
| JPS58210026A | Japan | A | |
| US4423040A | United States of America | A | |
| US4424210A | United States of America | A | |
| ZA833442B | South Africa | B | |
| US4444762A | United States of America | A | |
| US4461638A | United States of America | A | |
| DE2661009A1 | Germany | A1 | |
| CA1189338A | Canada | A | |
| US4525199A | United States of America | A | |
| EP0095169A3 | European Patent Office (EPO) | A3 | |
| JPS6037092B2 | Japan | B2 | |
| EP0160111A1 | European Patent Office (EPO) | A1 | |
| AU2771484A | Australia | A | |
| JPS60246301A | Japan | A | |
| US4562075A | United States of America | A | |
| AU2994584A | Australia | A | |
| FR2566626A1 | France | A1 | |
| JPS6127966A | Japan | A | |
| JPS6137701A | Japan | A | |
| DE160111T1 | Germany | T1 | |
| CA1208028A | Canada | A | |
| EP0077078B1 | European Patent Office (EPO) | B1 | |
| DE3273715D1 | Germany | D1 | |
| CA1220952A | Canada | A | |
| AU563866B2 | Australia | B2 | |
| AU566791B2 | Australia | B2 | |
| AU568590B2 | Australia | B2 | |
| US4762549A | United States of America | A | |
| AU577295B2 | Australia | B2 | |
| FR2566626B1 | France | B1 | |
| JPH038321B2 | Japan | B2 | |
| JPH0312062B2 | Japan | B2 | |
| DE2627772C2 | Germany | C2 | |
| US5108991A | United States of America | A | |
| EP0095169B1 | European Patent Office (EPO) | B1 | |
| AT80312TThis record | Austria | T | |
| ATE80312T1 | Austria | T1 | |
| DE3382616D1 | Germany | D1 | |
| DE3382616T2 | Germany | T2 | |
| DE2661009C2 | Germany | C2 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Ceased due to non-payment of the annual feeCeasedREN | REN | |
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Publication, DOCDB
- 80312
- Publication, EPODOC
- AT80312T
- Application
- 83105041
- Application, DOCDB
- 83105041
- Application, EPODOC
- AT19830105041T
Titles2
- English
- METHOD OF THE POWDER AGGREGATE FOR THE TRANSDERMAL ADMINISTRATION OF SYSTEMIC ACTIVE SUBSTANCES.
- German
- VERMITTLER DES DURCHDRINGUNGSVERMOEGENS ZUR TRANSDERMALEN VERABREICHUNG SYSTEMISCHER WIRKSTOFFE.
Classification
- CPC, 5
- A61K9/0014
- A61F2005/415
- A61K8/4906
- A61K47/22
- A61Q19/00
- IPC, 11
- A61K9 06
- A61F5 41
- A61K8 49
- A61K9 00
- A61K31 395
- A61K31 445
- A61K47 00
- A61K47 22
- A61L15 44
- A61Q19 00
- B01J19 00